5’-O-DMTr-2’-FU-Methyl Phosphonamidite 1 mg | ≥90% Cayman Chemical A nucleoside building block More Information Supplier Page × 5’-O-DMTr-2’-FU-Methyl Phosphonamidite
DMG-mPEG(1000) 50 mg | ≥90% Cayman Chemical A PEGylated derivative of DMG More Information Supplier Page × DMG-mPEG(1000)
DMG-mPEG(1000) 250 mg | ≥90% Cayman Chemical A PEGylated derivative of DMG More Information Supplier Page × DMG-mPEG(1000)
DMG-mPEG(1000) 100 mg | ≥90% Cayman Chemical A PEGylated derivative of DMG More Information Supplier Page × DMG-mPEG(1000)
Substance P (7-11) (trifluoroacetate salt) 50 mg | ≥98% Cayman Chemical A peptide fragment of substance P More Information Supplier Page × Substance P (7-11) (trifluoroacetate salt)
Substance P (7-11) (trifluoroacetate salt) 5 mg | ≥98% Cayman Chemical A peptide fragment of substance P More Information Supplier Page × Substance P (7-11) (trifluoroacetate salt)
Substance P (7-11) (trifluoroacetate salt) 25 mg | ≥98% Cayman Chemical A peptide fragment of substance P More Information Supplier Page × Substance P (7-11) (trifluoroacetate salt)
Substance P (7-11) (trifluoroacetate salt) 10 mg | ≥98% Cayman Chemical A peptide fragment of substance P More Information Supplier Page × Substance P (7-11) (trifluoroacetate salt)
Cavosonstat 50 mg | ≥98% Cayman Chemical An inhibitor of GSNOR More Information Supplier Page × Cavosonstat
Cavosonstat 5 mg | ≥98% Cayman Chemical An inhibitor of GSNOR More Information Supplier Page × Cavosonstat